Waters Full Spectrum Molecular Imaging and ACQUITY UPLC System Each Recognized at Pittcon 2015
March 12 2015 - 5:13PM
Business Wire
Waters Corporation (NYSE: WAT) announced today that both its new
full spectrum molecular imaging system and its
ACQUITY® UltraPerformance LC® (UPLC®) Technology received
awards at the 2015 Pittsburgh Conference on Analytical Chemistry
and Applied Spectroscopy.
The Waters Full Spectrum Molecular
Imaging System pinpoints, with greater specificity, the
distribution of large and small molecules within tissue samples. It
is the first system ever to allow scientists to access enhanced
matrix-assisted laser desorption ionization (MALDI) and desorption
electrospray ionization (DESI) with ion mobility separation (IMS)
in a single mass spectrometry platform. (Photo: Business Wire)
Introduced this week, the Waters® full spectrum molecular
imaging system was honored with the Pittcon Editors' Silver award
for the most innovative product at Pittcon.
Additionally, the ACQUITY UltraPerformance
LC Technology was recognized with the SelectScience Reviewers’
Choice Award, for the product with the best customer reviews and
ratings on SelectScience, a leading online resource for the global
scientific community.
Full Spectrum Molecular Imaging System
The full spectrum molecular imaging system is the first system
ever to allow scientists to access enhanced matrix-assisted laser
desorption ionization (MALDI) and desorption electrospray
ionization (DESI) with ion mobility separation (IMS) in a single
mass spectrometry platform.
Based on the Waters SYNAPT® G2-Si mass spectrometer, the imaging
capabilities of the new full spectrum molecular imaging system
enable research laboratories to pinpoint with greater specificity
the distribution of large and small molecules within tissue
samples. Information derived from imaging experiments can greatly
benefit cancer, cardiovascular and neuro-degenerative research by
measuring the distribution of molecules in cells and tissues. MS
imaging also allows researchers to identify different tissue types
based on their molecular composition.
“We are honored by the Pittcon editors' recognition,” said Dr.
Jeff Mazzeo, Sr. Director, Health Sciences, Waters Division. "By
combining MALDI with DESI and ion mobility on the same instrument,
Waters brings molecular imaging to a new level. We are committed to
giving cell biologists, biochemists, clinical researchers and
analytical scientists the tools they need to obtain a maximum
amount of information to advance their research into human health.
The new full spectrum molecular imaging system combines and
optimizes Waters' mass spectrometry technologies to deliver a level
of detail and molecular information beyond that of any individual
imaging technique."
Waters plans to begin shipments of its full spectrum molecular
imaging system in the third quarter of 2015.
ACQUITY UPLC Technology
First introduced in 2004, the ACQUITY UPLC System is acclaimed
for its enhanced speed, resolution and sensitivity, while also
improving the quality of results. By outperforming traditional or
optimized HPLC, the ACQUITY UPLC System allows chromatographers to
work at higher efficiencies with a much wider range of linear
velocities, flow rates, and backpressures.
"We are tremendously proud that the ACQUITY UPLC System was
recognized with the Reviewers’ Choice Award. This award is
particularly significant because it is decided on by the scientific
community, whose success is Waters’ ultimate mission,” said Ian
King Ph.D., Vice President, Separations Technology, Waters
Division. “Whether you work in methods development or quality
assurance, drug discovery or food safety testing, UPLC Technology
is proven to provide measurable scientific and business
benefits.”
UPLC Technology, which has been adopted successfully in
laboratories around the world for the most demanding separations,
is highly robust, dependable, and reproducible. What differentiates
the holistic design of ACQUITY UPLC systems is Waters’ patented 1.7
micron hybrid particle chemistry.
The ACQUITY UPLC System was a Pittcon Editor’s Gold Award winner
in 2004.
Please visit Waters.com for more details of the full portfolio
of ACQUITY UPLC systems.
About Waters Corporation
(www.waters.com)
For over 50 years, Waters Corporation (NYSE: WAT) has created
business advantages for laboratory-dependent organizations by
delivering practical and sustainable innovation to enable
significant advancements in such areas as healthcare delivery,
environmental management, food safety, water quality, consumer
products and high value-added chemicals worldwide.
Pioneering a connected portfolio of separations science,
laboratory information management, mass spectrometry and thermal
analysis, Waters technology breakthroughs and laboratory solutions
provide an enduring platform for customer success.
With revenue of $1.99 billion in 2014, Waters is driving
scientific discovery and operational excellence for customers
worldwide.
Waters, ACQUITY, UltraPerformance LC, UPLC, and SYNAPT are
trademarks or registered trademarks of Waters Corporation.
Photos/Multimedia Gallery Available:
http://www.businesswire.com/multimedia/home/20150312006533/en/
Waters CorporationChris Orlando, 508-482-2623Public Relations
ManagerChris_Orlando@waters.com
Waters (NYSE:WAT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Waters (NYSE:WAT)
Historical Stock Chart
From Apr 2023 to Apr 2024